Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIQ

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > How high will this go?

<< Previous

Bullboard Posts

Next >>

Post by pennyDoctoron Dec 09, 2019 1:59pm

761 Views

Post# 30436609

How high will this go?

I understand the 10 for one consolidation last year pre consolidation the price is still only .035 cents. That said, the stock could trade into $10.00 very quickly if Aximris gets a thumbs up from the FDA. The Regabatin is expected to be included in 2020. This could add another $5.00
potential 30+ bagger here. MERRY CHRISTMAS.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?